Great read, thanks for sharing
Analysts reports can be taken with a grain of salt, but still ~$6.50 from Cantor F. and now ~$4 from Bell Porter; are pretty significant upsides from where the SP is at $1.23.
Even if we take 50% of their estimates, we are looking at $2 to $3.25 range; that is quite good from where the SP is atm
But, do yourself a favour and read from Bell Porter these sections:
- Upside risk to our valuation
- Key near-term Catalysts
We can all get excited with out investment here again and provide quite a story for new investors too
GLTASHs
Cell Therapy News/Articles, page-295
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.015(1.40%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.12 | $1.08 | $11.51M | 10.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17804 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 230637 | 5 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.015 ( 1.85 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.12 | $1.08 | 1937390 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| MSB (ASX) Chart |